trending Market Intelligence /marketintelligence/en/news-insights/trending/aO7fiaqH_Y9nI-CizRNrGA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Allergan closes acquisition of personal, beauty products firm Envy Medical

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Allergan closes acquisition of personal, beauty products firm Envy Medical

Allergan PLC closed the acquisition of Envy Medical Inc., a personal and beauty products company that develops and markets skin treatments for both dermatologic or aesthetic conditions.

With the completion of this acquisition, Dublin-based Allergan has added the dermalinfusion skin treatment system to its portfolio.

Dermalinfusion in a noninvasive process used to treat a number of skin conditions. It works by simultaneously removing damaged cells, delivering specific serums and clearing the surface and pores of the skin.

Long Beach, Calif.-based Envy Medical's proprietary skin care products that will expand Allergan's SkinMedica portfolio.

Allergan did not disclose the financial details of the transaction.